New Research Published In Oncotarget Shows Inhibition Of MiR-10b With MN-anti-miR10b Nanodrug Targets Stem Cell-Like Properties In Metastatic Breast Cancer, Reducing Stemness And Preventing Metastasis In Mouse Models When Combined With Chemotherapy
《Oncotarget》杂志发表的最新研究表明，使用MN-anti-miR100亿纳米药物抑制MiR-100亿可以针对转移性乳腺癌中干细胞样特性，降低干细胞性质，并在小鼠模型中与化疗结合时阻止转移。
